期刊
JOURNAL OF FOOD AND DRUG ANALYSIS
卷 22, 期 1, 页码 105-115出版社
FOOD & DRUG ADMINSTRATION
DOI: 10.1016/j.jfda.2014.01.009
关键词
Functionalization; Genotoxicity; Graphene; Graphene oxide; Reduced graphene oxide; Toxicity
资金
- Intramural FDA HHS [FD999999] Funding Source: Medline
Graphene, a single-atom-thick carbon nanosheet, has attracted great interest as a promising nanomaterial for a variety of bioapplications because of its extraordinary properties. However, the potential for widespread human exposure raises safety concerns about graphene and its derivatives, referred to as graphene-family nanomaterials. This review summarizes recent findings on the toxicological effects and the potential toxicity mechanisms of graphene-family nanomaterials in bacteria, mammalian cells, and animal models. Graphene, graphene oxide, and reduced graphene oxide elicit toxic effects both in vitro and in vivo, whereas surface modifications can significantly reduce their toxic interactions with living systems. Standardization of terminology and the fabrication methods of graphene-family nanomaterials are warranted for further investigations designed to decrease their adverse effects and explore their biomedical applications. Copyright (C) 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据